Skip to content
A Green Sign – Lifestyle
Author:
multiQure SA
multiQure Begins Manufacturing Phase of MQ-201 Gene Therapy for First Huntington’s Disease Patients – U.S.-Based Andelyn Biosciences Selected as Manufacturing Partner
November 19, 2026